We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$27.9M
AUM Growth
+$12.7M
Cap. Flow
+$12.2M
Cap. Flow %
43.59%
Top 10 Hldgs %
17.59%
Holding
150
New
90
Increased
7
Reduced
6
Closed
47

Top Buys

Rank Stock Value
1
INSY
Insys Therapeutics, Inc.
INSY
+$637K
2
LYV icon
Live Nation Entertainment
LYV
+$625K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$462K
4
WAL icon
Western Alliance Bancorporation
WAL
+$461K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$460K

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$519K
2
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
+$510K
3
ESPR
Esperion Therapeutics
ESPR
+$443K
4
MUSA icon
Murphy USA
MUSA
+$440K
5
DGI
DigitalGlobe Inc.
DGI
+$374K

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Consumer Discretionary 13.09%
3 Healthcare 12.68%
4 Industrials 11.61%
5 Financials 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUNE
101
DELISTED
SUNEDISON, INC COM
SUNE
$83K 0.3%
154,148
+92,319
+149% +$213K
CHK
102
DELISTED
Chesapeake Energy Corporation
CHK
$78K 0.28%
+95
New +$67.3K
ZNGA
103
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$58K 0.21%
+25,400
New +$56.8K
ALGT icon
104
Allegiant Air
ALGT
$2.57B
– –
-1,367
Closed -$229K
ATI icon
105
ATI
ATI
$24.3B
– –
-11,189
Closed -$126K
CLB icon
106
Core Laboratories
CLB
$455M
– –
-2,764
Closed -$301K
CLDX icon
107
Celldex Therapeutics
CLDX
$2.94B
– –
-950
Closed -$223K
CRTO icon
108
Criteo S.A. Ordinary Shares
CRTO
$1.14B
– –
-5,322
Closed -$211K
DAR icon
109
Darling Ingredients
DAR
$9.32B
– –
-26,415
Closed -$278K
DNOW icon
110
DNOW Inc
DNOW
$2.44B
– –
-10,400
Closed -$165K
ESPR
111
DELISTED
Esperion Therapeutics
ESPR
– –
-19,912
Closed -$443K
FSLR icon
112
First Solar
FSLR
$21.4B
– –
-3,431
Closed -$226K
GEO icon
113
The GEO Group
GEO
$4B
– –
-11,879
Closed -$229K
GRPN icon
114
Groupon
GRPN
$1.03B
– –
-4,145
Closed -$255K
KW
115
DELISTED
Kennedy-Wilson Holdings
KW
– –
-8,589
Closed -$207K
LNW
116
DELISTED
Light & Wonder
LNW
– –
-18,699
Closed -$168K
MUSA icon
117
Murphy USA
MUSA
$11.4B
– –
-7,238
Closed -$440K
NOV icon
118
NOV
NOV
$6.84B
– –
-6,627
Closed -$222K
NWSA icon
119
News Corp Class A
NWSA
$15.6B
– –
-11,217
Closed -$150K
PAG icon
120
Penske Automotive Group
PAG
$14.7B
– –
-5,084
Closed -$215K
PCRX icon
121
Pacira BioSciences
PCRX
$1.04B
– –
-4,231
Closed -$325K
PTCT icon
122
PTC Therapeutics
PTCT
$6.18B
– –
-16,026
Closed -$519K
RES icon
123
RPC Inc
RES
$1.13B
– –
-14,227
Closed -$170K
SCOR icon
124
Comscore
SCOR
$113M
– –
-349
Closed -$287K
SHW icon
125
Sherwin-Williams
SHW
$83.5B
– –
-3,855
Closed -$334K
2 3 4
5
6

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q1 2016 Portfolio in Review

As of Q1 2016, Parametrica Management held 150 positions worth $27.9M, up 84% from $15.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Parametrica Management deployed $12.2M of net new capital in Q1 2016, opening 90 new positions and adding to 7 existing holdings. Its largest new stake was Insys Therapeutics, Inc.: 33,562 shares worth $537K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Finisar Corp, an estimated $315K trimmed.

  • Parametrica Management's largest Q1 2016 buy was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
  • Parametrica Management added most to CNH Industrial in Q1 2016, an estimated $424K increase.
  • Parametrica Management's biggest Q1 2016 reduction was Finisar Corp, cutting an estimated $315K.
  • Parametrica Management fully exited PTC Therapeutics in Q1 2016, selling an estimated $519K.
  • Parametrica Management's ten largest holdings make up 18% of its $27.9M portfolio in Q1 2016.
  • Parametrica Management opened 90 new positions and closed 47 in Q1 2016.
  • Parametrica Management's portfolio value rose 84% quarter-over-quarter to $27.9M.

Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.